Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis

OBJECTIVE: The aim of this study was to determine the efficacy and safety of lanthanum carbonate (LC) versus calcium salts, non-LC phosphate binders (PBs), sevelamer, or placebo in patients with chronic kidney disease (CKD). MATERIALS AND METHODS: A literature search on PubMed, Embase, and Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lijuan, Liu, An, Xu, Guoshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491672/
https://www.ncbi.nlm.nih.gov/pubmed/34602015
http://dx.doi.org/10.1080/0886022X.2021.1986068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491672/
https://www.ncbi.nlm.nih.gov/pubmed/34602015
http://dx.doi.org/10.1080/0886022X.2021.1986068

Ejemplares similares